Sézary syndrome (SS) is a leukemic variant of cutaneous T cell lymphoma (CTCL), and the neoplastic CD4+ T cells of SS patients undergo intense clonal proliferation. The gene discussed is CD4; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.